Related Experiment Video
Updated: May 4, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Collaboration between a drug information center and an academic detailing program
Christopher S Wisniewski1, Sophie Robert, Sarah Ball
1Christopher S. Wisniewski, Pharm.D., BCPS, is Assistant Professor of Clinical Pharmacy and Outcome Sciences, South Carolina College of Pharmacy, Medical University of South Carolina (MUSC) Campus, Charleston, and Clinical Pharmacy Specialist, Medication Use Policy and Informatics, MUSC. Sophie Robert, B.Pharm., Pharm.D., BCPP, is Clinical Pharmacy Consultant, SCORxE Academic Detailing Service, and Adjunct Assistant Professor, South Carolina College of Pharmacy, MUSC. Sarah Ball, Pharm.D., is Director, SCORxE Academic Detailing Service, and Assistant Professor, Department of Clinical Pharmacy and Outcome Sciences, South Carolina College of Pharmacy, University of South Carolina Campus, Columbia.
A collaboration between a drug information center (DIC) and an academic detailing program demonstrated mutual benefits. This partnership enhanced information access and efficiency for the detailing program and provided educational opportunities for the DIC.
Area of Science:
- Pharmacology and Pharmaceutical Sciences
- Health Services Research
- Medical Education
Background:
- Academic detailing programs aim to improve prescribing practices through evidence-based education.
- Drug Information Centers (DICs) are crucial resources for managing medication-related information.
- Effective collaboration between these entities can optimize drug information dissemination and utilization.
Purpose of the Study:
- To describe the collaboration between the South Carolina Offering Prescribing Excellence (SCORxE) academic detailing program and the Medical University of South Carolina (MUSC) Drug Information Center (DIC).
- To analyze the impact of this collaboration on the types and characteristics of drug information (DI) requests received by the MUSC DIC.
Main Methods:
- An agreement was established for the MUSC DIC to respond to DI questions from SCORxE academic detailing pharmacists.
- DI questions received by the MUSC DIC from May 2009 to October 2012 were analyzed.
- Analysis focused on comparing characteristics of SCORxE-generated questions with those from other sources, including question type and deadline.
Main Results:
- Out of 2727 DI questions, 62 (2.3%) originated from the SCORxE program.
- SCORxE questions were more frequently therapeutic consultations, reference searches, or dosage queries, and less often formulation or drug interaction inquiries.
- Academic detailing requests allowed significantly longer median deadlines (27.1 hours vs. 21.2 days). Learners (students/residents) handled the majority (68%) of SCORxE questions, with benefits including educational opportunities, funding, and scholarship for the DIC, and enhanced information access and efficiency for SCORxE.
Conclusions:
- The collaboration between the SCORxE academic detailing program and the MUSC DIC was mutually beneficial.
- The established process for question communication was simple and effective.
- Academic detailing questions required more in-depth research compared to other DI requests.
Related Concept Videos
Drug Discovery: Overview
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetics: Drug–Drug Interactions
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Drug Regulation

